Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

We conducted a pooled analysis of 869 individual newly diagnosed elderly patient data from 3 prospective trials. At diagnosis, a geriatric assessment had been performed. An additive scoring system (range 0-5), based on age, comorbidities, and cognitive and physical conditions, was developed to ident...

Full description

Bibliographic Details

Published in:	Blood Vol. 125; no. 13; p. 2068
Main Authors:	Palumbo, Antonio, Bringhen, Sara, Mateos, Maria-Victoria, Larocca, Alessandra, Facon, Thierry, Kumar, Shaji K, Offidani, Massimo, McCarthy, Philip, Evangelista, Andrea, Lonial, Sagar, Zweegman, Sonja, Musto, Pellegrino, Terpos, Evangelos, Belch, Andrew, Hajek, Roman, Ludwig, Heinz, Stewart, A Keith, Moreau, Philippe, Anderson, Kenneth, Einsele, Hermann, Durie, Brian G M, Dimopoulos, Meletios A, Landgren, Ola, San Miguel, Jesus F, Richardson, Paul, Sonneveld, Pieter, Rajkumar, S Vincent
Format:	Journal Article
Language:	English
Published:	United States 26.03.2015
Subjects:	Aged Aged, 80 and over Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Clinical Trials as Topic Cohort Studies Frail Elderly Geriatric Assessment Humans Multiple Myeloma - drug therapy Multiple Myeloma - mortality Prognosis Withholding Treatment - statistics & numerical data
ISSN:	1528-0020, 1528-0020
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!